Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Indian J Dermatol Venereol Leprol ; 2008 Jul-Aug; 74(4): 357-60
Article in English | IMSEAR | ID: sea-53013

ABSTRACT

BACKGROUND: Several modalities of treatment have been tried in vitiligo with varied results; however, Indian data on comparative studies of two or more therapies are limited. AIMS: We compared different phototherapy methods with an oral steroid as an adjunct to determine the method with the best tolerability and efficacy. METHODS: Eighty-six patients with progressive vitiligo were randomly assigned to different study groups according to a continuous selection method over a period of one year. Group 1 was given OMP + PUVA, group 2 OMP + UVB (NB), group 3 OMP + UVB (BB) and group 4 was given OMP alone. Each patient was followed up for six months and then released from treatment. Clinical evaluation was made at the end of three and six months. RESULTS: In group 1 (OMP + PUVA), marked improvement was seen in 18.51% while moderate improvement was seen in 66.66% of the patients. Marked improvement was seen in 37.03% in group 2 (OMP + NB-UVB) while 44.44% had moderate improvement. In group 3 (OMP + BB UVB), 8.33% showed marked improvement while moderate improvement was seen in 25% of the patients. Marked and moderate improvement was seen in 5 and 10% of group 4 (OMP) patients, respectively. CONCLUSIONS: Our study compared four treatment modalities in vitiligo patients, out of which oral minipulse of steroids (OMP) only had an adjunct value and was not very effective by itself. Narrow band UVB has a definite edge over broad band UVB and should be preferred when both options are available. NB-UVB and PUVA showed comparable efficacy.


Subject(s)
Administration, Oral , Adolescent , Adult , Child , Combined Modality Therapy , Disease Progression , Dose-Response Relationship, Drug , Drug Therapy, Combination , Humans , Middle Aged , PUVA Therapy , Steroids/administration & dosage , Treatment Outcome , Ultraviolet Therapy , Vitiligo/pathology , Young Adult
2.
Indian J Dermatol Venereol Leprol ; 2008 Mar-Apr; 74(2): 136-8
Article in English | IMSEAR | ID: sea-52487

ABSTRACT

We describe here multiple keratoacanthomas in an Human Immunodeficiency Virus (HIV)-seropositive 70 year-old man. The patient had multiple epithelial tumors of the skin showing rapid growth, histopathological features of a keratoacanthoma and a conspicuous tendency toward spontaneous remission. A diagnosis of nonfamilial multiple keratoacanthoma was established. The patient had a CD4 count of 633 cells/microL. The HIV disease in our patient was of a nonprogressive nature with CCR5-positive T cells.


Subject(s)
Aged , HIV Infections/complications , HIV Seropositivity/immunology , HIV-1/immunology , Humans , Keratoacanthoma/complications , Male , Time
SELECTION OF CITATIONS
SEARCH DETAIL